James Blachly

Academic / Other · 1 registered clinical trial.

Status	Trial	Phase	Started
Withdrawn	Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymp Prolymphocytic Leukemia, Recurrent Mantle Cell Lymphoma, Recurrent Small Lymphocytic Lymphoma	Phase 2	2015-03-12